Mechanisms of TNF-alpha-induced insulin resistance

G S Hotamisligil1

  • 1Harvard School of Public Health, Department of Nutrition, Boston, MA 02115, USA.

Insights

Tumor necrosis factor-alpha (TNF-alpha) contributes to insulin resistance. Removing TNF-alpha or its p55 receptor improves insulin sensitivity in obese mice, suggesting a key role in metabolic dysfunction.

Area of Science:

  • Metabolic Research
  • Immunology
  • Genetics

Background:

  • Insulin resistance is a complex metabolic disorder linked to elevated tumor necrosis factor-alpha (TNF-alpha).
  • The precise mechanisms by which TNF-alpha influences insulin resistance are not fully understood.
  • Investigating TNF-alpha's role requires studying its impact on insulin signaling pathways.

Purpose of the Study:

  • To investigate the direct relationship between TNF-alpha and insulin resistance.
  • To determine the specific roles of TNF-alpha receptors (p55 and p75) in mediating TNF-alpha-induced insulin resistance.
  • To elucidate the molecular targets of TNF-alpha in the development of insulin resistance.

Main Methods:

  • Utilized TNF-alpha-deficient and TNF-alpha receptor knockout mice (p55, p75, and double knockouts).
  • Induced obesity via diet in knockout and wild-type mice for comparative studies.
  • Performed glucose and insulin tolerance tests, and analyzed insulin receptor signaling and Glut 4 expression.

Main Results:

  • TNF-alpha-deficient obese mice exhibited significantly increased insulin sensitivity compared to wild-type controls.
  • Mice lacking the p55 TNF-alpha receptor, or both receptors, showed improved insulin sensitivity.
  • Enhanced insulin receptor tyrosine phosphorylation was observed in TNF-alpha knockout mice, indicating a key signaling defect.

Conclusions:

  • TNF-alpha plays a significant role in promoting insulin resistance, particularly in obese states.
  • The p55 receptor is a major mediator of TNF-alpha's detrimental effects on insulin sensitivity.
  • Targeting TNF-alpha signaling, especially via the p55 receptor, may offer therapeutic strategies for insulin resistance.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.